Copyright
©The Author(s) 2021.
World J Stem Cells. Aug 26, 2021; 13(8): 1094-1111
Published online Aug 26, 2021. doi: 10.4252/wjsc.v13.i8.1094
Published online Aug 26, 2021. doi: 10.4252/wjsc.v13.i8.1094
Figure 1 Basal commercial media used to produce induced pluripotent stem cell-derived mesenchymal stem cells.
The relative frequencies of media used by the 32 studies are displayed as number of events within each of the five categories of protocols being described: Mesenchymal stem cell Switch (A), Embryoid Bodies (B), Specific Differentiation (C), Pathway Inhibitor (D), and Platelet Lysate (E). DMEM: Dulbecco's modified Eagle's medium; DMEM/F12: Dulbecco's modified Eagle's medium F12; Ham's F12: Medium formulated for single-cell plating of near-diploid Chinese hamster ovary cells; HG-DMEM: High glucose Dulbecco's modified Eagle's medium; IMDM: Iscove's modified Dulbecco's media; KO-DMEM: Knockout Dulbecco's modified Eagle's medium; LG-DMEM: Low glucose Dulbecco's modified Eagle's medium; MEF: Mouse embryonic fibroblast media; αMEM/MEM: Minimum essential medium Eagle.
- Citation: Dupuis V, Oltra E. Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells. World J Stem Cells 2021; 13(8): 1094-1111
- URL: https://www.wjgnet.com/1948-0210/full/v13/i8/1094.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i8.1094